how effective is oral tirzepatide for weight loss Lilly orforglipron GLP-1 phase 3 trial Oral Tirzepatide: Transforming the Future

For other potential indications such as substance use disorders or depression, more randomized controlled trials in humans are still needed

This makes them an ideal choice for individuals experiencing nausea, reduced appetite, or other side effects commonly associated with GLP-1 medications

Medicare continues reimbursing telehealth mental health visits at office rates (extended through 2025 and likely beyond)

Three most recent trials including REDUCE-IT, STRENGTH and OMEMI trial have all consistently showed an increase in atrial fibrillation with omega-3 FA use

In the large randomized cardiovascular outcome trials, an increase in urinary tract infections were not observed (143,144,156)

In addition to improving peripheral insulin sensitivity, these agents also appear to have direct effects in the ovary, regulating steroid secretion, restoring ovulation, and increasing pregnancy rates (Froment and Touraine, 2006)